Fournier C. Tebentafusp: A New Systemic Treatment for Unresectable or Metastatic Uveal Melanoma in HLA-A*02:01-positive patients. Can Dermatol Today [Internet]. 2023 Sep. 29 [cited 2024 Aug. 14];4(3):5–10. Available from: https://canadiandermatologytoday.com/article/view/4-3-fournier